基于血液生物标志物的nomogram预测局部晚期鼻咽癌患者预后。

IF 4.2 3区 医学 Q2 CELL BIOLOGY
Mediators of Inflammation Pub Date : 2025-03-10 eCollection Date: 2025-01-01 DOI:10.1155/mi/6618728
Sisi Wang, Yuhua Feng, Jie Ling, Xiayan Zhao, Yanming Hu, Tao Hou, Yangchun Xie
{"title":"基于血液生物标志物的nomogram预测局部晚期鼻咽癌患者预后。","authors":"Sisi Wang, Yuhua Feng, Jie Ling, Xiayan Zhao, Yanming Hu, Tao Hou, Yangchun Xie","doi":"10.1155/mi/6618728","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> This study aimed to investigate the prognostic significance of the platelet-to-platelet distribution width ratio (P/PDW), systemic inflammation response index (SIRI), and systemic immune inflammation index (SII) in patients with locally advanced nasopharyngeal carcinoma (LA-NPC). <b>Methods:</b> A total of 549 LA-NPC patients were included in this retrospective analysis. Clinicopathological characteristics and blood test data were obtained from patient records. Receiver operating characteristic (ROC) curve analysis was employed to determine the optimal cutoff values for P/PDW, SIRI, and SII. The <i>χ</i> <sup>2</sup> test was used to compare clinicopathological characteristics. Survival rates were calculated using the Kaplan-Meier method. Prognostic factors were evaluated using univariate and multivariate analyses via Cox regression. Additionally, we developed a nomogram to predict outcomes and assessed its acuracy using the concordance index (C-index) and a calibration curve. <b>Results:</b> The median follow-up time was 47.1 months. Elevated P/PDW levels were associated with advanced N stages and higher risks of disease progression (all <i>p</i>  < 0.05). Patients with high SIRI or SII levels were more likely to have advanced T stages, clinical stages, and to develop metastasis (all <i>p</i>  < 0.05). Univariate analysis revealed that P/PDW, SIRI, SII, and T stage were significantly correlated with both overall survival (OS) and progression-free survival (PFS; all <i>p</i>  < 0.05). Clinical stage was significantly related only to PFS (<i>p</i>=0.009). Multivariate Cox regression analysis identified P/PDW (hazard ratio (HR): 0.544, 95% confidence interval (CI): 0.390-0.759, <i>p</i>  < 0.001; HR: 0.406, 95% CI: 0.268-0.615, <i>p</i>  < 0.001) and T stage (HR: 0.539, 95% CI: 0.378-0.768, <i>p</i>=0.001; HR: 0.545, 95% CI: 0.364-0.815, <i>p</i>=0.003) as independent prognostic factors for both OS and PFS, while SIRI (HR: 0.525, 95% CI: 0.333-0.827, <i>p</i>=0.006) was an independent predictor of OS. Nomogram C-indexes for the nomogram of OS were 0.717 and PFS were 0.711, respectively. Survival predictions and actual survival were consistent according to the calibration curve. <b>Conclusion:</b> Our findings suggest that P/PDW is a convenient and effective marker for predicting outcomes in LA-NPC patients.</p>","PeriodicalId":18371,"journal":{"name":"Mediators of Inflammation","volume":"2025 ","pages":"6618728"},"PeriodicalIF":4.2000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11986175/pdf/","citationCount":"0","resultStr":"{\"title\":\"Nomograms Based on Blood-Based Biomarkers for Predicting Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients.\",\"authors\":\"Sisi Wang, Yuhua Feng, Jie Ling, Xiayan Zhao, Yanming Hu, Tao Hou, Yangchun Xie\",\"doi\":\"10.1155/mi/6618728\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> This study aimed to investigate the prognostic significance of the platelet-to-platelet distribution width ratio (P/PDW), systemic inflammation response index (SIRI), and systemic immune inflammation index (SII) in patients with locally advanced nasopharyngeal carcinoma (LA-NPC). <b>Methods:</b> A total of 549 LA-NPC patients were included in this retrospective analysis. Clinicopathological characteristics and blood test data were obtained from patient records. Receiver operating characteristic (ROC) curve analysis was employed to determine the optimal cutoff values for P/PDW, SIRI, and SII. The <i>χ</i> <sup>2</sup> test was used to compare clinicopathological characteristics. Survival rates were calculated using the Kaplan-Meier method. Prognostic factors were evaluated using univariate and multivariate analyses via Cox regression. Additionally, we developed a nomogram to predict outcomes and assessed its acuracy using the concordance index (C-index) and a calibration curve. <b>Results:</b> The median follow-up time was 47.1 months. Elevated P/PDW levels were associated with advanced N stages and higher risks of disease progression (all <i>p</i>  < 0.05). Patients with high SIRI or SII levels were more likely to have advanced T stages, clinical stages, and to develop metastasis (all <i>p</i>  < 0.05). Univariate analysis revealed that P/PDW, SIRI, SII, and T stage were significantly correlated with both overall survival (OS) and progression-free survival (PFS; all <i>p</i>  < 0.05). Clinical stage was significantly related only to PFS (<i>p</i>=0.009). Multivariate Cox regression analysis identified P/PDW (hazard ratio (HR): 0.544, 95% confidence interval (CI): 0.390-0.759, <i>p</i>  < 0.001; HR: 0.406, 95% CI: 0.268-0.615, <i>p</i>  < 0.001) and T stage (HR: 0.539, 95% CI: 0.378-0.768, <i>p</i>=0.001; HR: 0.545, 95% CI: 0.364-0.815, <i>p</i>=0.003) as independent prognostic factors for both OS and PFS, while SIRI (HR: 0.525, 95% CI: 0.333-0.827, <i>p</i>=0.006) was an independent predictor of OS. Nomogram C-indexes for the nomogram of OS were 0.717 and PFS were 0.711, respectively. Survival predictions and actual survival were consistent according to the calibration curve. <b>Conclusion:</b> Our findings suggest that P/PDW is a convenient and effective marker for predicting outcomes in LA-NPC patients.</p>\",\"PeriodicalId\":18371,\"journal\":{\"name\":\"Mediators of Inflammation\",\"volume\":\"2025 \",\"pages\":\"6618728\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11986175/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mediators of Inflammation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/mi/6618728\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediators of Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/mi/6618728","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨血小板-血小板分布宽度比(P/PDW)、全身炎症反应指数(SIRI)、全身免疫炎症指数(SII)在局部晚期鼻咽癌(LA-NPC)患者中的预后意义。方法:对549例LA-NPC患者进行回顾性分析。临床病理特征和血液检查数据来自患者记录。采用受试者工作特征(ROC)曲线分析确定P/PDW、SIRI和SII的最佳截止值。采用χ 2检验比较临床病理特征。生存率采用Kaplan-Meier法计算。采用单因素和多因素Cox回归分析评估预后因素。此外,我们开发了一个nomogram来预测结果,并使用一致性指数(C-index)和校准曲线来评估其准确性。结果:中位随访时间为47.1个月。P/PDW水平升高与N分期晚期和疾病进展的高风险相关(均P < 0.05)。高SIRI或SII水平的患者更容易出现晚期T期、临床分期和转移(均p < 0.05)。单因素分析显示,P/PDW、SIRI、SII和T期与总生存期(OS)和无进展生存期(PFS)显著相关;p < 0.05)。临床分期仅与PFS相关(p=0.009)。多因素Cox回归分析发现P/PDW(风险比(HR): 0.544, 95%可信区间(CI): 0.390 ~ 0.759, P < 0.001;HR: 0.406, 95% CI: 0.268 ~ 0.615, p < 0.001)和T分期(HR: 0.539, 95% CI: 0.378 ~ 0.768, p=0.001;HR: 0.545, 95% CI: 0.364-0.815, p=0.003)是OS和PFS的独立预测因素,而SIRI (HR: 0.525, 95% CI: 0.333-0.827, p=0.006)是OS的独立预测因素。OS的Nomogram c指数为0.717,PFS的Nomogram c指数为0.711。根据校准曲线,生存预测与实际生存一致。结论:我们的研究结果表明,P/PDW是预测LA-NPC患者预后的一种方便有效的指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Nomograms Based on Blood-Based Biomarkers for Predicting Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients.

Purpose: This study aimed to investigate the prognostic significance of the platelet-to-platelet distribution width ratio (P/PDW), systemic inflammation response index (SIRI), and systemic immune inflammation index (SII) in patients with locally advanced nasopharyngeal carcinoma (LA-NPC). Methods: A total of 549 LA-NPC patients were included in this retrospective analysis. Clinicopathological characteristics and blood test data were obtained from patient records. Receiver operating characteristic (ROC) curve analysis was employed to determine the optimal cutoff values for P/PDW, SIRI, and SII. The χ 2 test was used to compare clinicopathological characteristics. Survival rates were calculated using the Kaplan-Meier method. Prognostic factors were evaluated using univariate and multivariate analyses via Cox regression. Additionally, we developed a nomogram to predict outcomes and assessed its acuracy using the concordance index (C-index) and a calibration curve. Results: The median follow-up time was 47.1 months. Elevated P/PDW levels were associated with advanced N stages and higher risks of disease progression (all p  < 0.05). Patients with high SIRI or SII levels were more likely to have advanced T stages, clinical stages, and to develop metastasis (all p  < 0.05). Univariate analysis revealed that P/PDW, SIRI, SII, and T stage were significantly correlated with both overall survival (OS) and progression-free survival (PFS; all p  < 0.05). Clinical stage was significantly related only to PFS (p=0.009). Multivariate Cox regression analysis identified P/PDW (hazard ratio (HR): 0.544, 95% confidence interval (CI): 0.390-0.759, p  < 0.001; HR: 0.406, 95% CI: 0.268-0.615, p  < 0.001) and T stage (HR: 0.539, 95% CI: 0.378-0.768, p=0.001; HR: 0.545, 95% CI: 0.364-0.815, p=0.003) as independent prognostic factors for both OS and PFS, while SIRI (HR: 0.525, 95% CI: 0.333-0.827, p=0.006) was an independent predictor of OS. Nomogram C-indexes for the nomogram of OS were 0.717 and PFS were 0.711, respectively. Survival predictions and actual survival were consistent according to the calibration curve. Conclusion: Our findings suggest that P/PDW is a convenient and effective marker for predicting outcomes in LA-NPC patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Mediators of Inflammation
Mediators of Inflammation 医学-免疫学
CiteScore
8.70
自引率
0.00%
发文量
202
审稿时长
4 months
期刊介绍: Mediators of Inflammation is a peer-reviewed, Open Access journal that publishes original research and review articles on all types of inflammatory mediators, including cytokines, histamine, bradykinin, prostaglandins, leukotrienes, PAF, biological response modifiers and the family of cell adhesion-promoting molecules.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信